Loading...
Loading...
India's loperamide imports from IRELAND total $518 across 1 shipments from 1 foreign suppliers. NEWLIFE BIOPHARMA LIMITED leads with $518 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include ZYDUS LIFESCIENCES LIMITED. This corridor reflects India's pharmaceutical import demand for loperamide — a concentrated sourcing relationship with select suppliers from IRELAND.

NEWLIFE BIOPHARMA LIMITED is the leading Loperamide supplier from IRELAND to India, with import value of $518 across 1 shipments. The top 5 suppliers — NEWLIFE BIOPHARMA LIMITED — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | NEWLIFE BIOPHARMA LIMITED | $518 | 1 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ZYDUS LIFESCIENCES LIMITED | $518 | 1 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Loperamide suppliers from IRELAND to India include NEWLIFE BIOPHARMA LIMITED. The leading supplier is NEWLIFE BIOPHARMA LIMITED with import value of $518 USD across 1 shipments. India imported Loperamide worth $518 USD from IRELAND in total across 1 shipments.
India imported Loperamide worth $518 USD from IRELAND across 1 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Loperamide sourced from IRELAND include ZYDUS LIFESCIENCES LIMITED. The largest buyer is ZYDUS LIFESCIENCES LIMITED with $518 in imports across 1 shipments.
The total value of Loperamide imports from IRELAND to India is $518 USD, across 1 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists